169 related articles for article (PubMed ID: 15877808)
21. Sensitive measurement of fragmented red cell population using flow cytometry, and its application for estimating thrombotic microangiopathy after stem cell transplantation.
Toba K; Tsuchiyama J; Hashimoto S; Ichida T; Kato K; Watanabe K; Furukawa T; Narita M; Takahashi M; Aizawa Y
Cytometry B Clin Cytom; 2004 Mar; 58(1):39-46. PubMed ID: 14994374
[TBL] [Abstract][Full Text] [Related]
22. Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
Chilver-Stainer L; Lämmle B; Alberio L
Thromb Haemost; 2004 Feb; 91(2):276-82. PubMed ID: 14961154
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation.
Miyata R; Shimazu M; Tanabe M; Kawachi S; Hoshino K; Wakabayashi G; Kawai Y; Kitajima M
Liver Transpl; 2007 Oct; 13(10):1455-62. PubMed ID: 17902122
[TBL] [Abstract][Full Text] [Related]
24. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
26. Beyond the platelet count: heparin antibodies as independent risk predictors.
Stribling WK; Slaughter TF; Houle TT; Sane DC
Am Heart J; 2007 Jun; 153(6):900-6. PubMed ID: 17540189
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.
Kennedy GA; Bleakley S; Butler J; Mudie K; Kearey N; Durrant S
Transfusion; 2009 Sep; 49(9):1884-9. PubMed ID: 19453982
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.
Kanamori H; Maruta A; Sasaki S; Yamazaki E; Ueda S; Katoh K; Tamura T; Otsuka-Aoba M; Taguchi J; Harano H; Ogawa K; Mohri H; Okubo T; Matsuzaki M; Watanabe S; Koharazawa H; Fujita H; Kodama F
Bone Marrow Transplant; 1998 Apr; 21(7):705-9. PubMed ID: 9578311
[TBL] [Abstract][Full Text] [Related]
29. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
[TBL] [Abstract][Full Text] [Related]
30. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
Chang JJ; Parikh CR
Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
[TBL] [Abstract][Full Text] [Related]
31. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
32. Heparin-induced thrombocytopenia: diagnosis and management.
Hassell K
Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
[TBL] [Abstract][Full Text] [Related]
33. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
Bream-Rouwenhorst HR; Hobbs RA
Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
[TBL] [Abstract][Full Text] [Related]
34. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
35. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
36. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
[TBL] [Abstract][Full Text] [Related]
37. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
38. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
Kannan M; Saxena R; Adiguzel C; Fareed J
Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
[TBL] [Abstract][Full Text] [Related]
39. Changes of clotting factors (7, 9 and 10) and hepatocyte growth factor in patients with thrombotic microangiopathy after bone marrow transplantation.
Takatsuka H; Nakajima T; Nomura K; Okikawa Y; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H; Ogawa H
Clin Transplant; 2006; 20(5):640-3. PubMed ID: 16968491
[TBL] [Abstract][Full Text] [Related]
40. Management of cancer-associated thrombotic microangiopathy: what is the right approach?
Werner TL; Agarwal N; Carney HM; Rodgers GM
Am J Hematol; 2007 Apr; 82(4):295-8. PubMed ID: 17034030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
